Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure

ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure

US Patent 8263072 · Granted Sep 11, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Autologous bone graft substitute composition comprising bioceramic particles of 2023
Autologous bone graft substitute composition2023
Autologous bone graft substitute composition2023
External load bearing distracting device for an articulating anatomical joint2022
Autologous bone graft substitute2021
Autologous bone graft substitute2021
Methods and compositions for regenerating articular cartilage2014
Methods of preventing ischemia/reperfusion damage to kidney using antibodies tha2014
Methods of preventing ischemia/reperfusion damage to kidney using antibodies tha2014
Therapies for acute renal failure2014
Method and device for repairing the larynx, trachea and other fibrocartilaginous2014
Therapies for chronic renal failure2013